Clinical and dosimetric aspects in concurrent radiotherapy with CDK4/6 inhibitors in breast cancer

被引：0
|
作者：
Rebegea, Laura Florentina [1 ,2 ,3 ]
Ilie, Ana Maria [1 ]
Anghel, Rodica [4 ]
Lungu, Mihaela [2 ,5 ]
Dumitru, Mihaela Emilia [1 ]
机构：
[1] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Radiotherapy, Galati 800578, Romania
[2] Univ Galatzi, Fac Med & Pharm, Dept Clin Med, Galati, Romania
[3] Univ Galatzi, Res Ctr Field Med & Pharmaceut Sci, ReFORM UDJ, Galati, Romania
[4] Carol Davila Univ Med & Pharm, Dept Clin Med, Bucharest, Romania
[5] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Neurol, Galati 800578, Romania
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
radiotherapy; CDK4/6i; toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2226
引用
收藏
页码：S632 / S633
页数：3
相关论文
共 50 条
  • [1] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [2] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Marie Robert
    Jean-Sébastien Frenel
    Emmanuelle Bourbouloux
    Dominique Berton Rigaud
    Anne Patsouris
    Paule Augereau
    Carole Gourmelon
    Mario Campone
    Drugs, 2018, 78 : 1353 - 1362
  • [3] An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
    Robert, Marie
    Frenel, Jean-Sebastien
    Bourbouloux, Emmanuelle
    Rigaud, Dominique Berton
    Patsouris, Anne
    Augereau, Paule
    Gourmelon, Carole
    Campone, Mario
    DRUGS, 2018, 78 (13) : 1353 - 1362
  • [4] Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
    George, Mridula A.
    Qureshi, Sadaf
    Omene, Coral
    Toppmeyer, Deborah L.
    Ganesan, Shridar
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
  • [6] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [7] The Role of CDK4/6 Inhibitors in Breast Cancer
    Conleth G. Murphy
    Current Treatment Options in Oncology, 2019, 20
  • [8] CDK4/6 inhibitors in luminal breast cancer
    Gnant, Michael
    Steger, Guenther G.
    Bartsch, Rupert
    LANCET ONCOLOGY, 2015, 16 (01): : 2 - 3
  • [9] First clinical experience with CDK4/6 inhibitors in breast cancer therapy
    Cobec, Ionut Marcel
    Moleriu, Lavinia
    Moatar, Aurica Elisabeta
    Rempen, Andreas
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (05)
  • [10] Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer
    Barroso-Sousa, Romualdo
    Shapiro, Geoffrey I.
    Tolaney, Sara M.
    BREAST CARE, 2016, 11 (03) : 167 - 173
12345